%0 Journal Article %T Impact of Dapagliflozin Therapy on Renal Protection and Kidney Morphology in Patients With Uncontrolled Type 2 Diabetes Mellitus %A Akira Yoshida %A Fumio Miyamoto %A Hideaki Jinnouchi %A Hiroyuki Nishimura %A Katsunori Jinnouchi %A Keizo Kajiwara %A Kunio Hieshima %A Motoko Tanaka %A Noboru Kurinami %A Seigo Sugiyama %A Tomio Jinnouchi %A Tomoko Suzuki %J Journal of Clinical Medicine Research %D 2018 %R https://doi.org/10.14740/jocmr3419w %X Background: We examined whether the sodium-glucose cotransporter-2 inhibitor (SGLT2i) dapagliflozin can improve urine albumin-to-creatinine ratio (UACR) associated with a reduction in body weight or body fat in patients with type 2 diabetes mellitus (T2DM). %U https://www.jocmr.org/index.php/JOCMR/article/view/3419